REFERENCES
- Jereb B, Ong R L, Mohan M, et al. Redefined role of radiation in combined treatment of Ewing sarcoma. Pediatr Oncol Hematol 1986; 3: 111–118
- Marec-Berard P, Philip T. Ewing sarcoma: the pediatrician poin of view. Pediatr Blood Cancer 2004; 42: 477–480, [INFOTRIEVE], [CROSSREF], [CSA]
- Craft A, Cotterill S, Malcolm A, et al. Ifosfamide-containing chemotherapy in Ewing sarcoma: the second United Kingdom children's cancer study group and the medical research council Ewing tumor study. J Clin Oncol 1998; 16: 3628–3633, [INFOTRIEVE], [CSA]
- Dunst J, Jürgens H, Sauer R, et al. Radiation therapy in Ewing sarcoma: an update of the CESS 86 trial. Int J Radiat Oncol Biol Phys 1995; 32: 919–930, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Nesbit M E, Gehan E A, Burgert O B, Jr, et al. Multimodal therapy for the menagement of primary, nonmetastatic Ewing sarcoma of bone: a long-term follow-up of the first intergroup study. J Clin Oncol 1990; 8: 1664–1674, [INFOTRIEVE], [CSA]
- Kinsella T J, Miser J S, Waller B, et al. Long-term follow-up of Ewing sarcoma of bone treated with combined modality therapy. Int J Radiat Oncol Biol Phys 1991; 20: 389–395, [PUBMED], [INFOTRIEVE], [CSA]
- Schuck A, Ahrens S, Paulussen M, et al. Local therapy in localised Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials. Int J Radiat Oncol Biol Phys. 2003; 55: 168–177, [INFOTRIEVE], [CROSSREF], [CSA]
- Rodriguez-Galindo C, Spunt S L, Pappo A S. Treatment of Ewing sarcoma family of tumors: current status and outlook for the future. Med Pediatr Oncol 2003; 40: 276–287, [INFOTRIEVE], [CROSSREF], [CSA]
- Paulussen M, Ahrens S, Dunst J, et al. Localised Ewing tumor of bone: final results of the cooperative Ewing sarcoma study CESS 86. J Clin Oncol 2001; 19: 1818–1829, [INFOTRIEVE], [CSA]
- Scully S P, Temple H T, O'Keefe R J, et al. Role of surgical resection in pelvic Ewing's sarcoma. J Clin Oncol 1995; 13: 2336–2341, [INFOTRIEVE], [CSA]
- Yang R -S, Eckardt J J, Eilber F R, et al. Surgical indications for Ewing sarcoma of the pelvis. Cancer 1995; 76: 1388–1397, [INFOTRIEVE], [CSA]
- Bacci G, Toni A, Avella M, et al. Long-term results in 144 localized Ewing sarcoma patients treated with combined therapy. Cancer 1989; 63: 1477–1486, [INFOTRIEVE], [CSA]
- Ozaki T, Hillmann A, Hoffmann C, et al. Significance of surgical margin on the prognosis of patients with Ewing sarcoma. Cancer 1996; 78: 892–900, [INFOTRIEVE], [CROSSREF], [CSA]
- Cotterill S J, Ahrens S, Paulusse M, et al. Prognostic factors in Ewing tumor of bone: analysis of 975 patients from the European intergroup cooperative Ewing sarcoma study group. J Clin Oncol 2000; 18: 3108–3114, [PUBMED], [INFOTRIEVE], [CSA]
- Kutluk M T, Yalcin B, Akyuz C, et al. Treatment results and prognostic factors in Ewing sarcoma. Pediatr Hematol Oncol 2004; 21: 597–610, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Burdach S, Jurgens H. High-dose chemotherapy (HDC) in the Ewing family of tumors (EFT). Crit Rev Oncol Hematol 2002; 41: 169–189, [INFOTRIEVE], [CSA]
- Strauss S J, McTiernan, Driver D, et al. Single center experience of a new intensive induction therapy for Ewing family of tumors: feasibility, toxicity, and stem cell mobilization properties. J Clin Oncol 2003; 15: 2974–2981, [CROSSREF], [CSA]
- Kasper B, Lehnert T, Bernard L, et al. High-dose chemotherapy with autologous peripheral blood stem cell transplantation for bone and soft-tissue sarcomas. Bone Marrow Transplant 2004; 34: 37–41, [INFOTRIEVE], [CROSSREF], [CSA]
- Evans R G, Burgert E O, Gilchrist G S, et al. Sequential half-body irradiation (SHBI) and combination chemotherapy as salvage treatment for failed Ewing sarcoma: a pilot study. Int J Radiat Oncol Biol Phys 1984; 10: 2363–2368, [INFOTRIEVE], [CSA]
- Craft A W, Cotterill S J, Bullimore J A, Pearson D. Long-term results from the first UKCCSG Ewing tumour study (ET-1). Eur J Cancer 1997; 33: 1061–1069, [INFOTRIEVE], [CROSSREF], [CSA]
- Paulussen M, Ahrens S, Lehnert M, et al. Second malignancies after Ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study. Ann Oncol 2001; 12: 1619–1630, [INFOTRIEVE], [CROSSREF], [CSA]
- Fuchs B, Valenzuela R G, Inwards C, et al. Complications in long-term survivors of Ewing sarcoma. Cancer 2003; 15: 2687–2692, [CROSSREF], [CSA]
- Rosen G, Caparros B, Nirenberg A, et al. Ewing sarcoma: ten-year experience with adjuvant chemotherapy. Cancer 1981; 47: 2204–2213, [INFOTRIEVE], [CSA]
- Bacci G, Ferrari S, Bertoni F, et al. Prognostic factors in non- metastatic Ewing sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Instituto Ostopedico Rizoli. J Clin Oncol 2000; 18: 4–11, [INFOTRIEVE], [CSA]
- Shankar A G, Pinkerton C R, Atra A, et al. Local therapy and other factors influencing site of relapse in patients with localised Ewing sarcoma. Eur J Cancer 1999; 12: 1698–1704, [CROSSREF], [CSA]
- Martin R C, 2nd, Brennan M F. Adult soft tissue Ewing sarcoma or primitive neuroectoderm tumors: predictors of survival. Arch Surg 2003; 138: 281–285, [INFOTRIEVE], [CROSSREF], [CSA]
- Zoubek A, Dockhorn-Dwornniczak B, Delattre O, et al. Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients?. J Clin Oncol 1996; 14: 1245–1251, [INFOTRIEVE], [CSA]